NCT00063648View on ClinicalTrials.gov

Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

December 31, 2007

Conditions

Liver DiseaseLymphoproliferative Disorders

Interventions

BIOLOGICAL

EBV-specific autologous CTL

Trial Locations (1)

77030

Texas Children's Hospital, Houston

All Listed Sponsors

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00063648 - Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant | Biotech Hunter | Biotech Hunter